Page 7 - HFA_Dateline_2017_Q4_Winter

FACTOR REPLACEMENT REFLECTS THE
PROTECTION WITHIN

References: 1. Peyvandi F, Garagiola I, Young G. The past and future For people with hemophilia, Factor treatment temporarily
of haemophilia: diagnosis, treatments, and its complications. Lancet. replaces what’s missing.1 With a long track record of proven
2016;388:187-197. 2. Wolberg AS. Plasma and cellular contributions results, Factor treatment works with your body’s natural
to fibrin network formation, structure and stability. Haemophilia. blood clotting process to form a proper clot.2,3
2010;16(suppl 3):7-12. 3. King MW. Introduction to blood coagulation. Brought to you by Shire, dedicated to pursuing advancements
http://themedicalbiochemistrypage.org/blood-coagulation.php. Last in hemophilia for more than 60 years.
modified January 2, 2017. Accessed November 21, 2016.
Stay empowered by the possibilities.
©2017 Shire US Inc., Lexington, MA 02421.
All rights reserved. 1-800-828-2088. 5/8/17 7:08 AM
Shire and the Shire Logo are registered trademarks of
Shire Pharmaceutical Holdings Ireland Limited or its affiliates. S28150 01/17

HEMP16CRCH0737_JA_7_5x4_625_JUNE_B&W.indd 1

Talk to your doctor to see if
ADYNOVATE may be right for you.

For more information, please visit

www.ADYNOVATE.com

©2016 Shire US Inc., Lexington, MA 02421. All rights reserved. 1-800-828-2088.
SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates.
ADYNOVATE is a registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.
S32930 06/17

Winter 2017 | Dateline Federation 7